Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272857 · ClinicalTrials.gov registry record · Phase 1
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
A Phase 1 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00272857 is a Phase 1 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 3 participants.
The verdict
NCT00272857, a Phase 1 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Fanconi anemia (FA) is a disease that affects an individual's bone marrow. It is caused by a defective gene in the bone marrow cells that produce various types of blood cells. Individuals with FA may experience fatigue, bleeding, and increased infections. The purpose of this study is to evaluate the safety and effectiveness of a gene transfer procedure in generating new, healthy cells in individuals with FA.
Interventions
- GENETIC Retrovirus Construct
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272857
The ClinicalTrials.gov registry entry for NCT00272857 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retrovirus Construct is the first listed.
NCT00272857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272857 about?
NCT00272857 is a clinical study titled "Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia". Fanconi anemia (FA) is a disease that affects an individual's bone marrow. It is caused by a defective gene in the bone marrow cells that produce various types of blood cells. Individuals with FA may experience fatigue, bleeding, and increased infections. The purpose of this study is to evaluate the...
What is the current status of trial NCT00272857?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00272857?
The interventions under investigation include: Retrovirus Construct (GENETIC).
Who is sponsoring clinical trial NCT00272857?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.